Skip to content

Leber Congenital Amaurosis 9 C1837873

Published: July 22, 2026Updated: August 20, 2026

Leber Congenital Amaurosis 9 is a rare inherited condition causing severe vision impairment from infancy. It damages the retina, the light-sensitive part of the eye. Researchers are studying gene therapy as a potential treatment approach.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Profound vision loss

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Nystagmus

(ophthalmologic)

Photophobia

(ophthalmologic)

Keratoconus

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

CEP290 gene therapy (when eligible)

For LCA-9 associated with CEP290 mutations, emerging antisense oligonucleotide therapies and gene editing approaches are being investigated in clinical trials.

procedure
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Kidney function screening

Regular monitoring for renal involvement associated with LCA-9 (Joubert syndrome spectrum), including ultrasound and renal function tests.

monitoring

Additional treatment options

Environmental modifications

Home and school adaptations including improved lighting, contrast enhancement, and safety modifications to maximize functional vision and prevent accidents.

lifestyle

Sensory enrichment therapy

Multisensory stimulation programs combining auditory, tactile, and olfactory experiences to support neural development and enhance sensory processing.

complementary

Family support and education

Comprehensive family education about LCA-9 prognosis, genetic implications, and available resources, along with support for caregiver well-being.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Leber Congenital Amaurosis 9 C1837873?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Leber Congenital Amaurosis 9 C1837873. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy